Date
Thursday, August 20, 2026

 

Time
11:00 AM (UTC-04:00) Eastern Time (US & Canada)

 

Duration
60 minutes

 

Credit Type
Physicians, Physician Associates/Assistants, Nurses, Nurse Practitioners, Psychologists, Social Workers (ASWB ACE), Counselors, Marriage and Family Counselors

 

Intended Learners

This activity is designed for all behavioral or allied health professionals, CEOs, presidents and vice presidents, directors, other C-suite executives, physicians, psychologists, social workers, marriage and family therapists, alcohol and drug counselors, mental health counselors, clinical counselors, collegiate recovery and professional monitoring organizations, EAPs, nurses, nurse practitioners, physician associates/assistants, peer support, recovery coaches, sober living operators, and staff. 

 

Learning Objectives

1. Differentiate between traditional cannabis products and high-potency THC concentrates, and describe current trends in cannabis use among adolescents and young adults. 

2. Evaluate the relationship between chronic cannabis use and adverse mental health outcomes, including anxiety, depression, impaired social and occupational functioning, and the risk of early-onset psychosis and first-episode psychosis.  

3. Identify evidence-based assessment and treatment strategies for cannabis use disorder, including appropriate clinical interventions and levels of care.

 

Continuing Education

In support of improving patient care, HMP Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.  Note: This statement is not an indication of approved credits. Please see website for full accreditation details, including credit types and totals, for this activity.